A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancerCapsule Summary
Background: Modern radiotherapy is associated with dermatitis (RD) in approximately one-third of patients treated for breast cancer. There is currently no standard for treating RD. Objective: The objective of this study was to determine whether LUT014, a topical BRAF inhibitor which paradoxically ac...
Saved in:
Main Authors: | Sanford Katz, MD (Author), Doug Ciuba, MD (Author), Antoni Ribas, MD, PhD (Author), Noa Shelach, PhD (Author), Galit Zelinger, BS (Author), Briana Barrow, BS (Author), Benjamin W. Corn, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
by: Raphael Reinhard, MD, et al.
Published: (2018) -
Correlation Analysis of Erectile Dysfunction with Lower Urinary Tract Symptoms (LUTS) Degree and Clinical Features in LUTS Patients
by: Lei WANG, et al.
Published: (2018) -
Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy
by: Jasmine Rana, MD, et al.
Published: (2021) -
Pollakiuria due to Constipation in a Girl: LUTS or PEDUF?
by: Selim Kurtoğlu
Published: (2022) -
PREVENTION AND TREATMENT OF RADIODERMATITIS: AN INTEGRATIVE REVIEW
by: Franciane Schneider, et al.
Published: (2013)